B Group, Inc. Iovance Biotherapeutics, Inc. Put Options Transaction History
B Group, Inc.
- $130 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IOVA
# of Institutions
286Shares Held
233MCall Options Held
1.12MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$67.8 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$58.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$49.7 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$27.7 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$23.1 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $369M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...